{
    "url_original": "https://www.wsj.com/articles/pfizer-asks-fda-to-authorize-second-covid-19-booster-dose-11647384010?mod=politics_lead_pos12",
    "url": "pfizer-asks-fda-to-authorize-second-covid-19-booster-dose-11647384010",
    "title": "Pfizer Asks FDA to Authorize Second Covid-19 Booster Dose",
    "sub_head": "Pfizer and partner BioNTech file application for people 65 years and older",
    "category_1": "Health",
    "time": "2022-03-15 18:40:00",
    "body": "Pfizer Inc.  and partner  BioNTech  SE have asked U.S. health regulators to authorize a second booster dose of their Covid-19 vaccine for people 65 years and older.<br />The companies said Tuesday that they had filed the application. The Food and Drug Administration is expected to make a decision in time for the Biden administration to begin a potential fall vaccine campaign."
}